| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Adarx Pharmaceuticals, Inc. (ADRX) have been net buyers, picking up 5,161,516 shares worth roughly $87.7M on balance. In the past 30 days, 5 insiders bought and 0 sold. Recent activity has leaned to the buy side.
Leading the buying is GORDON CARL L (Director, 10% Owner). Notably, 1 of the recent buyer ranks in the top tier of our insider score, which grades how well a person's past trades have anticipated price moves.
Classified under Biotechnology (Healthcare sector), ADRX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 11.09M | - | - | |
| 10% | 10.69M | - | +950.0K | |
| 10% | 10.69M | - | +950.0K | |
| 10% | 4.96M | - | +1.60M | |
| 10% | 4.45M | - | +1.60M |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | Chimovits Erez | Director | Buy | 61,516 | $17.00 | $1,045,772.00 | +0.7% | |
| Sep 28, 2026 | Gordon Carl L74 | Director, 10% Owner | Buy | 950,000 | $17.00 | $16,150,000.00 | -262.6% | |
| Sep 28, 2026 | Orbimed Advisors LLC66 | Director, 10% Owner | Buy | 950,000 | $17.00 | $16,150,000.00 | -262.6% | |
| Sep 28, 2026 | Sr One Capital Management, LLC52 | 10% Owner | Buy | 1,600,000 | $17.00 | $27,200,000.00 | -158.8% | |
| Sep 28, 2026 | George Simeon | Director, 10% Owner | Buy | 1,600,000 | $17.00 | $27,200,000.00 | -158.8% |